Refine
Has Fulltext
- yes (4)
Is part of the Bibliography
- yes (4)
Year of publication
- 2011 (4) (remove)
Document Type
- Doctoral Thesis (4)
Language
- English (4) (remove)
Keywords
- Bindestelle (1)
- Bindungsstellen (1)
- CaV1.2 und PMCA4b (1)
- Calcium-ATPasen (1)
- Calciumkanal (1)
- Cav1.2 and PMCA4b (1)
- Furchungsteilung (1)
- Genfallen-Insertion (1)
- Genregulation (1)
- Interaktion (1)
- Ionenkanal (1)
- Japankärpfling (1)
- Kanalkinetik (1)
- Kinetik (1)
- Mena (1)
- Mena promoter ativity (1)
- Mena-Promotor-Aktivität (1)
- Midblastula-transition MBT MZT (1)
- Neurobiologie (1)
- Nicotinischer Acetylcholinrezeptor (1)
- PDZ-Domain (1)
- Protein-Interaktionspartner (1)
- Proteine (1)
- Rezeptor (1)
- Spectrin (1)
- Transkription <Genetik> (1)
- VASP (1)
- Vasodilatator-stimuliertes Phosphoprotein (1)
- X-Gal staining (1)
- X-Gal-Färbung (1)
- Zellvolumen (1)
- Zygote (1)
- binding sites (1)
- gene-trap (1)
- interacting PDZ domain (1)
- kinetics (1)
- nAChR (1)
- neurobiology (1)
- receptor channel (1)
Institute
- Physiologisches Institut (4) (remove)
The voltage –gated calcium channel, Cav1.2, and the plasma membrane calcium ATPase, PMCA4b, play important roles in excitable and non-excitable cells. The central function of Cav1.2 is to regulate the calcium entry into cells upon depolarization, while PMCA4b is responsible for calcium extrusion and has an influence on cellular calcium homeostasis. Both proteins control fundamental functions in the heart and brain, but the specific functions and the precise mechanisms are still investigated. In order to identify new interaction partners that may regulate the activities of the Cav1.2 and the PMCA4b, we used three independent assays and co-localization studies. The assays, which were used are PDZ domain arrays (testing 124 different PDZ domains), GST pull-downs, and conventional immunoprecipitation assays. In the PDZ arrays, strongest interactions with Cav1.2 and PMCA4b were found for the PDZ domains of MAST-205, MAGI-1, MAGI-2, MAGI-3, and ZO-1. Additionally, we established interactions between Cav1.2 and the PDZ domains of NHERF1/2, Mint-2, and CASK. PMCA4b was observed to interact with Mint-2, and its interactions with Chapsyn-110 and CASK were confirmed. Furthermore, we validated interaction of Cav1.2 and PMCA4b with NHERF1, CASK, MAST-205 and MAGI-3 via immunoprecipitation. We also demonstrated direct interaction of the C-terminus of Cav1.2 and the PDZ domain of nNOS. We assumed that nNOS overexpression would reduce Ca2+ influx through Cav1.2. To address this question, we measured Ca2+ currents in stably transfected HEK 293 cells expressing the Cav1.2 (α1b and β2a subunit of the smooth muscle L-type calcium channel) and nNOS. It has been shown that NO modulates ion channel activity by nitrosylation of sulfhydryl groups on the channel protein. So we propose that the interaction between the C-terminus of Cav1.2 and the PDZ domain of nNOS inhibits the currents by an S-nitrosylation of the channel protein. All these interactions connect both proteins to signaling networks involved in signal transmission, cell adhesion, and apoptosis, which may help provide new hints about the physiological functions of Cav1.2 and PMCA4b in intra- and intercellular signaling.
The nicotinic acetylcholine receptor of skeletal muscle is one of the best-investigated synaptic proteins and often serves as model for the entire family of pentameric ligand gated ion channels (pLGICs). Receptors of this superfamily share a common architecture. After binding the agonist the characteristic C-loop structure closes around the ligand-binding site and triggers a wave of conformational changes that spread through the protein and finally result in the opening of the channel gate. As shown before, high-resolution single channel data can hardly be described by simple kinetic mechanisms (Parzefall et al., 1998, Hallermann et al., 2005). Recent advances in the field of kinetic modelling on receptor currents demonstrate that the introduction of additional short lived shut states in kinetic schemes enhances the quality of estimates of reaction rates. The additional shut states that immediately follow ligand bound states in the mechanism are suggested to resemble the closing movement of the C-loop (Lape et al., 2008; Mukhtasimova et al., 2009). It has not been described yet whether and how the structural differences of the 2 binding sites of the receptor influence the opening behaviour. To address this question, high-resolution single channel recordings, in combination with agonists that are known to exhibit different binding site selectivity, were performed. Thereby, a detailed description of the binding site dependent generation of channel currents is possible. At the embryonic mouse-muscle receptor used in this study the ligand binding sites are located at the α-γ and α-δ subunit interfaces. By allocation of opening characteristics to the α-δ and α-γ sites it is possible to show the binding site dependent activation of distinct kinetic states. Furthermore, it will be shown that the recently introduced short-lived shut states are sufficient to describe high-resolution single channel data. Finally an enhanced kinetic mechanism based on the ‘primed states’ model, published in 2009 by Mukhtasimova et al., will be presented. In this model the structurally diverse α-δ and α-γ binding sites elicit different kinetic channel characteristics. Thus the complex high-resolution kinetic characteristics of the embryonic receptor can be described coherently.
Characterisation of Mena Promoter Activity and Protein Expression in Wild-type and Gene-trapped Mice
(2011)
Proteins of the Ena/VASP protein family are important regulators of actin and participate in cell-cell and cell-matrix adhesions. To date, the physiological importance of Ena/VASP proteins for integrity of the cardiovascular system has remained unclear. To study cardiovascular functions of Mena and VASP, we used an established VASP knockout mouse in combination with a novel gene-trap-based model to ablate Mena function. In the mutated Mena mouse, the endogenous Mena gene is disrupted by the insertion of a β-galactosidase construct and β-galactosidase expression is under the control of the endogenous Mena promoter. X-gal staining of mouse organs revealed Mena promoter activity in smooth muscle layers of vessels, intestines and bronchioles, but also in cells of the brain, in cardiomyocytes and in the respiratory epithelium of bronchioles. In wild-type mice, Western blotting revealed differing protein expression patterns of VASP and Mena. Mena expression was observed in almost every tissue, predominantly in heart, lung, stomach, large intestine, testis, brain and eye. Additionally, the neuronalspecific Mena isoform was expressed in brain, eye, and slightly in heart and stomach. VASP protein, in contrast, was predominantly detected in spleen and thrombocytes. In gene-trapped mice, Mena expression was largely reduced in heart, lung and stomach but only slightly decreased in brain and testis. Immunofluorescence microscopy revealed colocalisation of Mena and F-actin at intercalated discs of cardiomyocytes and strong colocalisation of Mena and α- smooth-muscle-actin in vessels and bronchioles. Functional analysis of Mena/VASP-mutated and wild-type mice using electrocardiography suggested that the depletion of either Mena or VASP does not interfere with normal heart function. However, in double-deficient mice, the resting heart rate was significantly increased, probably reflecting a mechanism to compensate defects in ventricle contraction and to maintain a normal cardiac output. In agreement, cardiac catheter investigations suggested dilated cardiomyopathy in doubledeficient mice. Thus, although Western blot analysis showed differing protein expression patterns of Mena and VASP, these findings suggest that Mena and VASP mutually compensate for each other. Concerning Mena, we propose an important role of the protein in vessel walls, cardiomyocytes and bronchioles.
The study of animal development is one of the oldest disciplines in the field of biology and the collected data from countless investigations on numerous species have formed a general understanding of the animal life-cycle. Almost one century ago, one consequence of these intense investigations was the discovery of specific morphological changes that occur during the cleavage phase, a period that follows fertilization and egg activation at the very beginning of animal embryogenesis. These observations resulted into the formulation of the concept of a midblastula transition (MBT). So far, the mechanism of the nucleo-cytoplasmic ratio model is the only one that explains MBT regulation in a satisfying way. It suggests that the MBT is controlled by several maternal repressive factors in the egg, which are titrated out by every cell division until they lose their repressing potential. Although this regulatory mechanism was proven for several species and in different approaches, it is still only a rudimentary model for MBT control and leaves numerous questions unanswered. On this conceptual background, this thesis has shown that embryos from the medaka fish (Oryzias latipes) lose their cell cycle synchrony already after the fourth or fifth round of cell divisions, and replace it by a metasynchronous divisions pattern, in which cell division occurs in clear waves beginning in the embryo's center. The reason for this change in division mode is still unknown, although several hypotheses were put forward, most notable a difference in yolk-access between cells. However, this theory was weakened by division waves that progressed from one embryonic pole to the opposing one, which were occasionally observed in deformed embryos, leaving the mechanism for this phenomenon furthermore unclear. Those deformed embryos were most likely the result of asymmetric cell divisions at very early stages, a phenomenon which occurred in a significant percentage of medaka embryos and which directly influenced the equal distribution of cytoplasmic material. It could not beuncovered what kind of effects this unequal distribution of cytoplasm exerted on the progression of embryonic development, but it can be argued that relevant differences in cell volumes could result in cell clusters that will enter MBT at different time points. Comparable observations were already made in other species and it was hypothesized that they were the direct results of early unequal cell cleavages. Finally, it was demonstrated that zygotic transcription in medaka embryos is activated prior to the hitherto assumed time of the first transcriptional initiation. Moreover, indications were found that strongly speak for a transcriptional activation that occurs in two steps; a first step at the 16-cell stage when first cells were identified positive for RNAPII phosphorylation, and a second step at the 64-cell stage, when the number of p-RNAPII positive cells significantly increased. A stepwise activation of zygotic transcription was already observed in other species, but only for the overall increasing amount of mRNAs and irrespective of the actual number of transcriptionally active cells within the embryos. .. Overall, these data confirm and expand the basic knowledge of pre-MBT embryos and about the MBT itself. Furthermore, they also suggest that many early processes in pre-MBT embryos are only rudimentarily understood or still totally unknown.